Xtx Topco LTD Gamida Cell Ltd. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.04 - $0.46 $5,430 - $62,455
135,773 New
135,773 $5,000
Q3 2023

Nov 13, 2023
BUY
$0.85 - $1.87 $25,672 - $56,479
30,203 New
30,203 $31,000
Q3 2022

Nov 14, 2022
BUY
$1.53 - $3.39 $94,988 - $210,464
62,084 New
62,084 $99,000
Q3 2021

Nov 12, 2021
SELL
$3.85 - $6.44 $50,592 - $84,628
-13,141 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$5.85 - $8.33 $76,874 - $109,464
13,141 New
13,141 $84,000

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email